Allworth Financial’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.3K Buy
4,132
+2,168
+110% +$20.9K ﹤0.01% 2318
2026
Q1
$14.6K Buy
1,964
+663
+51% +$6.98K ﹤0.01% 3220
2025
Q4
$15.3K Buy
1,301
+40
+3% +$432 ﹤0.01% 2980
2025
Q3
$9.73K Buy
1,261
+994
+372% +$6.96K ﹤0.01% 3154
2025
Q2
$1.95K Sell
267
-233
-47% -$1.88K ﹤0.01% 3711
2025
Q1
$5.04K Buy
500
+275
+122% +$3.43K ﹤0.01% 2753
2024
Q4
$3.26K Buy
225
+200
+800% +$3.11K ﹤0.01% 2957
2024
Q3
$369 Hold
25
﹤0.01% 3486
2024
Q2
$363 Hold
25
﹤0.01% 3452
2024
Q1
$393 Hold
25
﹤0.01% 3343
2023
Q4
$405 Sell
25
-375
-94% -$6.14K ﹤0.01% 3177
2023
Q3
$4.92K Hold
400
﹤0.01% 2108
2023
Q2
$6.43K Hold
400
﹤0.01% 2009
2023
Q1
$6.96K Sell
400
-182
-31% -$2.59K ﹤0.01% 1919
2022
Q4
$5.38K Buy
582
+56
+11% +$522 ﹤0.01% 1868
2022
Q3
$5K Buy
+526
New +$5.22K ﹤0.01% 1887
2021
Q2
Sell
-374
Closed -$18K 1632
2021
Q1
$18K Buy
+374
New +$19.5K ﹤0.01% 823

Other funds holding NEO

Allworth Financial's NEO Position: Q2 2026 in Review

Allworth Financial increased its NeoGenomics (NEO) stake by 110% in Q2 2026, buying an estimated $20.9K and bringing the position to 4,132 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Allworth Financial first reported a position in NEO in Q1 2021 and has held it in 17 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Allworth Financial held 4,132 shares of NeoGenomics worth $60.3K as of Q2 2026.
  • Allworth Financial bought 2,168 NeoGenomics shares in Q2 2026, an estimated $20.9K.
  • NeoGenomics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2318 holding.
  • Allworth Financial first reported a position in NeoGenomics in Q1 2021 and has held it in 17 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.